Mountain View, CA, United States of America

Jaroslaw Kalisiak

This inventor holds 33 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 7 EPO patents, primarily in Immuno-Oncology. Top assignees: Chemocentryx, Inc., Arcus Biosciences, Inc.. Active years: 2017-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jaroslaw Kalisiak. Retrieved from https://idiyas.com/inventor/jaroslaw-kalisiak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 33 (Patent Applications = 6)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 7 (Patent Applications = 8)

Average Co-Inventor Count = 11.0

ph-index = 7

Forward Citations = 155(Granted Patents)

Company Filing History:

Arcus Biosciences, Inc.

patents

Years Active: 2017-2025

Loading Chart...

Areas of Expertise:

Adenosine Modulators

Arginase Inhibitors

Chemokine Receptors

C5aR Antagonists

CCR2 Modulators

HIF-2alpha Inhibitors

Immune Enhancers

Substituted Tetrahydropyrans

Tetralin Compounds

Ecto-5'-Nucleotidase

CXCR2 Inhibitors

CCR6 Compounds

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12459967 - Modulators of 5'-nucleotidase, ecto and the use thereof (2025-11-04),

2. 12433836 - Parenterally administered immune enhancing drugs (2025-10-07),

3. 12226425 - Inhibitors of ARG1 and/or ARG2 (2025-02-18),

4. 12168023 - Inhibitors of adenosine 5'-nucleotidase (2024-12-17),

5. 12145901 - Process for preparing tetralin compounds (2024-11-19),

6. 12103907 - Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha (2024-10-01),

7. 12054500 - Arginase inhibitors (2024-08-06),

8. 12054484 - Substituted tetrahydropyrans as CCR2 modulators (2024-08-06),

9. 11945805 - Inhibitors of CXCR2 (2024-04-02),

10. 11845729 - Processes and intermediates in the preparation of C5aR antagonists (2023-12-19),

11. 11820759 - Modulators of chemokine receptors (2023-11-21),

12. 11787762 - Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha (2023-10-17),

13. 11667662 - Modulators of 5'-nucleotidase, ecto and the use thereof (2023-06-06),

14. 11407712 - Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α (2022-08-09),

15. 11267845 - Inhibitors of CD73-mediated immunosuppression (2022-03-08),

Title: Inventor Jaroslaw Kalisiak

Introduction: Jaroslaw Kalisiak is a talented inventor based in Mountain View, CA. He is known for his innovative contributions to various fields.

Latest Patents: Jaroslaw Kalisiak holds several patents in the areas of technology and engineering, showcasing his dedication to pushing boundaries and creating new solutions.

Career Highlights: Throughout his career, Jaroslaw Kalisiak has demonstrated a keen ability to identify problems and develop inventive solutions. His work has significantly impacted the industry and inspired many aspiring inventors.

Collaborations: Jaroslaw Kalisiak has collaborated with leading companies and research institutions to bring his ideas to life. His partnerships have been instrumental in turning concepts into tangible products that benefit society.

Conclusion: In conclusion, Jaroslaw Kalisiak is a visionary inventor whose passion for innovation continues to drive him towards creating groundbreaking solutions. His contributions have left a lasting impact on the world of inventions.

Profile summary based on public USPTO records.